The Role of the XMD Dog in the Assessment of Myoblast Transfer Therapy
The success of myoblast transfer therapy can be assessed in a variety of ways. However, from the point of view of the utilization of experimental models in the development of this form of therapy, the methods used to determine its success depend on the particular biological questions that are being addressed.
KeywordsMuscular Dystrophy Satellite Cell Duchenne Dystrophy Single Muscle Cell Obligate Carrier
Unable to display preview. Download preview PDF.
- 1.B.J. Cooper, N.J. Winand, H. Stedman, B.A. Valentine, E.P. Hoffman, L.M. Kunkel, M. Oronzi Scott, K.H. Fischbeck, J.N. Kornegay, R.J. Avery, J.R. Williams, R.D. Schmickel, and J.E. Sylvester, The homologue of the Duchenne locus is defective in X-linked muscular dystrophy of dogs. Nature 334: 154–156 (1988).PubMedCrossRefGoogle Scholar